Results: 67

Afibercept treatment for macular edema with and without serous retinal detachment due to branch retinal vein occlusion

Arq. bras. oftalmol; 86 (1), 2023
ABSTRACT Purpose: To evaluate the effectiveness of intravitreal aflibercept treatment for macular edema with and without serous retinal detachment due to branch retinal vein occlusion. Methods: Thirty-seven eyes with branch retinal vein occlusion treated with intravitreal aflibercept injection for macu...

Effects of the epiretinal membrane on the outcomes of intravitreal dexamethasone implantation for macular edema secondary to branch retinal vein occlusion

Arq. bras. oftalmol; 86 (1), 2023
ABSTRACT Purpose: To investigate the effects of epiretinal membrane formation on the clinical outcomes of intravitreal dexamethasone implantation for macular edema secondary to branch retinal vein occlusion. Methods: This retrospective interventional case series includes the treatment of naive patients...

Ranibizumab intravítreo para el tratamiento de oclusiones vasculares retinianas: análisis mediante tomografía de coherencia óptica
Intravitreal Ranibizumab for the Treatment of Retinal Vascular Occlusions: Analysis Using Optical Coherence Tomography

Introducción: El uso del medicamento ranibizumab intravítreo favorece la reducción del edema macular generador de las oclusiones vasculares retinianas causantes de la pérdida visual. Objetivo: Evaluar la eficacia y seguridad de la administración intravítreo de ranibizumab en el cambio de espesor ...

Disorganization of the inner retinal layers in diabetic macular edema: systematic review

Rev. bras. oftalmol; 81 (), 2022
ABSTRACT The objective of this article was to review the disorganization of inner retinal layers as a biomarker in diabetic macular edema. A systematic search was conducted in PubMed®/MEDLINE®, Cochrane and Embase until August 2021. The keywords used were: "disorganization of inner retinal layers (DRIL...

Protocolo assistencial de injeções intravítreas do HCPA: edema macular diabético

Clin. biomed. res; 42 (2), 2022
RESUMO: O edema macular diabético é uma das principais causas de baixa visual no mundo e a indicação mais frequente de injeções intravítreas no Hospital de Clínicas de Porto Alegre. O tratamento com injeção intra-vítrea de medicamentos anti-vascular endothelial growth factor, incluindo o bevac...

Lente intraocular subluxado y edema macular quístico tratado con vitrectomía pars plana, Yamane y Ozurdex
Subluxated intraocular lens and cystoid macular edema treated with pars plana vitrectomy, Yamane and Ozurdex

Rev. cuba. oftalmol; 34 (4), 2021
El edema macular es el engrosamiento anormal de la mácula asociado con la acumulación de líquido en el espacio extracelular de la retina neurosensorial. En algunos casos también se ha observado edema intracelular que comprende las células de Muller. Una de estas causas es el edema macular poscirugí...

Unilateral intravitreal dexamethasone implant for the treatment of cystoid macular edema in intermediate uveitis

Rev. bras. oftalmol; 80 (2), 2021
ABSTRACT This report aims to describe the effectiveness of a unilateral intravitreal dexamethasone implant (Ozurdex®) used for the treatment of cystoid macular edema in a patient with recurrent intermediate uveitis. Bearing in mind the adverse effects of the prolonged use of systemic corticosteroids, th...

Efectividad de la dorzolamida en el tratamiento del edema quístico macular poscirugía de catarata
Effectiveness of dorzolamide in the treatment of cystoid macular edema after cataract surgery

Rev. cuba. oftalmol; 33 (4), 2020
Objetivo: Evaluar la efectividad del tratamiento combinado con dorzolamida tópica en pacientes con edema quístico macular poscirugía de catarata. Métodos: Se realizó un estudio experimental en pacientes atendidos en el Servicio de Vítreo-Retina del Instituto Cubano de Oftalmología "Ramón Pando...

Three versus five intravitreal aflibercept injections as the initial loading phase in the treatment of diabetic macular edema: one-year results

Arq. bras. oftalmol; 83 (5), 2020
ABSTRACT Purpose: To compare the efficacy of three initial monthly intravitreal aflibercept injections followed by pro re nata (3+PRN) dosing versus five initial monthly intravitreal aflibercept injections followed by pro re nata (5+PRN) dosing in patients with diabetic macular edema. Methods: A total ...

Immune modulator therapy compared with vitrectomy for management of complicated intermediate uveitis: a prospective, randomized clinical study

Arq. bras. oftalmol; 83 (5), 2020
ABSTRACT Purpose: To compare the benefits and side effects of pars plana vitrectomy with those of systemic immune modulator therapy for patients with complicated intermediate uveitis. Methods: This prospective clinical trial enrolled patients with recurrent intermediate uveitis who exhibited minimal im...